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Abstract
Background  and  objectives:  Many  conditions  such  as  bacterial  and  viral  infectious  diseases,
mechanical  obstruction  due  to  air  and  calculi  and  drugs  can  cause  parotitis.  We  present  a  case
of unusual  bilateral  parotitis  in  a  patient  under  non-invasive  continuous  positive  airway  pressure
(CPAP) therapy  for  chronic  obstructive  pulmonary  disease  exacerbation  in  intensive  care  unit.
Case report:  A  36-year-old  patient  was  admitted  to  intensive  care  unit  with  the  diagnosis  of
chronic obstructive  pulmonary  disease  exacerbation.  Antibiotherapy,  bronchodilator  therapy
and non-invasive  positive  pressure  ventilation  were  applied  as  treatment  regimen.  Painless
swellings  developed  on  the  3rd  day  of  admission  on  the  right  and  a  day  after  this  on  the
left parotid  glands.  Amylase  levels  were  increased  and  ultrasonographic  evaluation  revealed
bilateral parotitis.  No  intervention  was  made  and  the  therapy  was  continued.  The  patient  was
discharged  on  the  6th  day  with  clinical  improvement  and  regression  of  parotid  swellings  without
any complications.
Conclusions:  Parotitis  may  have  occurred  after  retrograde  air  ﬂow  in  the  Stensen  duct  during
CPAP application.  After  the  exclusion  of  possible  viral  and  bacteriological  etiologies  and  possible
drug reactions  we  can  focus  on  this  diagnosis.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
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Resumo
Justiﬁcativa  e  objetivos:  Muitas  condic¸ões  podem  causar  parotidite,  incluindo  doenc¸as  infec-
ciosas virais  e  bacterianas,  obstruc¸ão  mecânica  por  causa  da  presenc¸a  de  ar,  cálculos  e
medicamentos.  Apresentamos  um  caso  de  parotidite  bilateral  incomum  em  um  paciente
sob tratamento  com  pressão  positiva  contínua  não  invasiva  das  vias  aéreas  (PPCVA)  para
exacerbac¸ão da  doenc¸a  pulmonar  obstrutiva  crônica  em  unidade  de  terapia  intensiva.
Relato de  caso: Paciente  de  36  anos,  internado  em  unidade  de  terapia  intensiva  com  diag-
nóstico de  exacerbac¸ão  da  doenc¸a  pulmonar  obstrutiva  crônica.  Antibioterapia,  terapia
broncodilatadora  e  ventilac¸ão  com  pressão  positiva  não  invasiva  foram  aplicadas  como  regime
de tratamento.  No  terceiro  dia  de  internac¸ão,  inchac¸os  indolores  desenvolveram-se  à  direita
da glândula  parótida  e,  depois,  à  esquerda.  Os  níveis  de  amilase  aumentaram  e  o  exame  ultra-
ssonográﬁco  revelou  parotidite  bilateral.  Nenhuma  intervenc¸ão  foi  feita  e  o  tratamento  foi
continuado.  O  paciente  recebeu  alta  no  sexto  dia,  com  melhoria  clínica  e  regressão  do  inchac¸o
da parótida,  sem  complicac¸ões.
Conclusões:  A  parotidite  pode  ter  ocorrido  após  o  ﬂuxo  retrógrado  de  ar  do  duto  de  Stensen
durante  a  aplicac¸ão  de  PPCVA.  Após  a  exclusão  de  possíveis  etiologias  virais  e  bacteriológicas
e possíveis  reac¸ões  medicamentosas,  podemos  focar  no  diagnóstico.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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arotitis  is  one  of  the  most  commonly  encountered  condi-
ions  among  non-neoplastic  disorders  of  the  salivary  glands.1
umps,  other  viral  and  bacterial  infections,  duct  calculi,
jögren’s  disease,  and  drug  reactions  can  be  listed  as  rea-
ons  for  acute  parotitis.2 One  of  the  most  common  reasons
f  drug  induced  parotitis  is  the  use  of  iodine  and  iodine  con-
aining  drugs  as  contrast  agents.  Parotitis  formed  due  to
odine  is  named  as  ‘‘iodine  mumps’’.3,4 Many  other  drugs
ther  than  iodine  can  form  parotitis  as  well.  Among  these
rugs  are  phenylbutazone,  oxyphenbutazone;  chlormethia-
ole,  methimazole;  epinephrine;  naproxen;  phenothiazine
ntipsychotics  as  promazine  and  thioridazine;  clozapine;
rganophosphate  insecticides;  l-asparaginase,  cytarabine;
-2  blockers  such  as  famotidine,  cimetidine,  ranitidine;
nterferon  alfa;  trimipramine;  methyldopa;  nifedipine,
icardipine;  isoproterenol;  ritodrine;  ACE  inhibitors  as  cap-
opril,  ramipril,  enalapril;  antibiotics  such  as  cefuroxime,
oxycycline,  minocycline,  nitrofurantoin,  sulfadiazine,and
rimethoprim  sulfametoxazole.5,6
We  present  a  case  of  bilateral  parotitis  in  a  patient
nder  non-invasive  CPAP  therapy  for  chronic  obstructive
ulmonary  disease  (COPD)  exacerbation  in  intensive  care
nit.
ase report
 36-year-old  patient  with  congenital  bronchiectasis  was
dmitted  to  intensive  care  unit  with  the  diagnosis  of  COPD.
ntibiotherapy,  bronchodilator  therapy  and  non-invasive
ositive  pressure  ventilation  were  applied  as  treatment
egimen.  Painless  swellings  developed  on  the  3rd  day  of
t
e
s
udmission  on  the  right  and  a  day  after  this  on  the  left
arotid  glands.  Ultrasonographic  (USG)  evaluation  revealed
arotitis.  Blood  amylase  levels  were  197  and  3010  U/L
espectively  on  the  2nd  and  4th  days  of  gland  swelling.
umps  ELISA  revealed  IgM(−) and  IgG(+).  The  patient’s  drug
herapy  consisted  of  ranitidine  1  ×  50  mg  iv,  sulbactam  ampi-
illin  4  ×  1  g  iv,  clarithromycin  2  ×  500  mg  iv,  acetylcysteine
 ×  600  mg  iv,  methylprednisolone  2  ×  40  mg  iv,  ipratropium
romide  4  ×  0.5  mg  inh,  salbutamol  4  ×  2.5  mg  inh,  and
udesonide  2  ×  0.25  mg  inh.  The  patient  was  discharged  on
he  6th  day  with  clinical  improvement  and  regression  of
arotid  swellings  without  any  complications.  After  10  days
he  patient  had  polyclinic  control,  where  the  blood  amy-
ase  level  was  measured  as  125  U/L  and  the  parotid  USG
as  reported  as  mild  parotitis  bilaterally.  COPD  drug  treat-
ent  was  regulated  and  the  patient  was  sent  home  with
uggestions.
iscussion
he  etiological  mechanisms  of  parotitis  comprise  mechani-
al  trauma,  infection,  hypersensitivity  reactions,  obstruc-
ion  of  parotid  ducts  with  calculi,  air  and  thickened
ecretions,  parasympathetic  stimulation,  muscle  relaxation,
nd  drug  reactions  (type  A  and  type  B).7,8 Our  patient
ad  some  of  these  risk  factors.  With  ranitidine,  which  the
atient  was  using,  there  had  been  reports  of  drug  induced
arotitis.9,10 Such  patients  had  resulted  in  recovery  with  dis-
ontinuation  of  the  drug,  whereas  our  patient  used  the  drug
hroughout  the  hospital  stay.  Despite  this,  the  patient  recov-
red  spontaneously.  Moreover,  the  patient  had  no  ﬁndings
uch  as  fever,  rush  or  eosinophilia  that  would  have  guided
s  to  adverse  drug  reaction.  Modiﬁed  Naranjo  Probability
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Scale  can  be  used  to  establish  the  diagnosis  of  drug  induced
parotitis.6
Besides  this,  increased  oral  cavity  pressure  due  to  pos-
itive  airway  pressure  application  as  a  treatment  regimen
may  have  caused  retrograde  air  movement  in  the  Stensen
duct  and  obstruction,  and  this  may  have  resulted  in  paroti-
tis.  Akcaboy  et  al.  and  Baykal  et  al.  blamed  retrograde  air
ﬂow  into  the  parotid  gland  and  intraoral  pressure  rise  in  the
development  of  postoperative  parotitis.11,12 The  condition
associated  with  inﬂammation  of  the  parotid  gland  due  to
retrograde  air  ﬂow  in  the  parotid  ducts  is  named  as  pneu-
moparotitis.  This  condition  is  characterized  with  painless
swelling  and  crepitations.13,14 The  reasons  can  be  listed  as
habit  of  cheek  inﬂation,  cough  attacks  in  asthma  exacerba-
tion,  straining  and  coughing  during  anesthesia,  conditions
with  increased  intraoral  pressure,  dental  instrumentations,
balloon  inﬂation,  and  wind  instrument  use.14 Our  patient
had  intermittent  positive  airway  pressure  application  as
treatment  regimen.  This  may  have  been  associated  with
pneumoparotitis  due  to  increased  intraoral  cavity  pressure.
Both  the  parotid  glands  of  the  patient  had  painless  swellings,
but  no  crepitation  was  determined.  Ultrasonographic  eval-
uation  revealed  no  ﬁndings  of  air,  but  detailed  examination
to  determine  the  presence  of  air  was  not  performed.  Com-
puted  tomography  would  have  demonstrated  more  clear
results.
Unilateral  parotitis  is  generally  due  to  duct  obstruction,
whereas  bilateral  parotitis  is  more  commonly  attributed  to
a  systemic  disease.15 We  suggested  Stensen  duct  obstruction
with  air,  rather  than  a  systemic  disease  as  the  probable  eti-
ological  factor  in  our  patient.  Bilateral  parotitis  formed  as
a  result  of  duct  obstruction  is  a  rather  uncommon  situation.
Moreover,  there  is  no  report  of  parotitis  after  CPAP  in  the
literature.
We  have  not  investigated  viral  and  bacteriological  rea-
sons  for  parotitis  other  than  mumps  in  our  patient.  These
factors  should  have  been  considered  as  well.
Parotitis  can  occur  after  retrograde  air  ﬂow  in  the
Stensen  duct  during  CPAP  application.  After  the  exclusion
of  other  possible  viral  and  bacteriological  etiologies  in  addi-
tion  to  the  measurement  of  mumps  antibodies  and  possible
drug  reactions,  we  can  focus  on  this  diagnosis.
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